Safety
-
Platinol and Platinol-AQ (cisplatin) for injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – September 2010
ADVERSE REACTIONS
New Information to following subsections:
- Nephrotoxicity
- Hematologic
- Other Events
-
-







